Additional file 2 of Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin

Additional file 2: Suppl. Table 1. It contains a) the clinical data relative to the 14 melanoma patients whose biopsies were collected before starting MAPKi therapy and b) the expression levels of nestin by immunohistochemistry (IHC) in these biopsies that have been determined counting positive cells in at least ten fields and expressed as percentage of positivity.

补充文件2：补充表1（Suppl. Table 1）。该数据集包含两项内容：a) 14例黑色素瘤患者的临床资料，其活检样本均采集于丝裂原活化蛋白激酶抑制剂（MAPKi）治疗开始前；b) 上述活检样本中巢蛋白（nestin）的免疫组织化学（immunohistochemistry, IHC）表达水平，该表达水平通过计数至少10个视野内的阳性细胞数计算得到，并以阳性细胞百分比的形式进行表征。